Down-regulation of LATS1 expression due to its promoter hyper-methylation was also observed in breast cancer, colorectal cancer and astrocytoma (Takahashi et al., 2005; Jiang et al., 2006; Wierzbicki et al., 2013). Here, LATS1 is linked to breast carcinoma.